A handful of people mill around a conference room at Baxter International's headquarters in Deerfield, Illinois, sugaring their coffee or shaking hands in greeting. Windows look out on Interstate 94 as morning commuters pick their way down the Edens Expressway into Chicago. Norbert Riedel, the company's chief scientific officer, smiles as he strides into the room. "Share price yesterday gained 80 cents, which is a good sign," Riedel tells his staff.
Survey Series
For Advertisers
Back to Basics
Norbert Riedel's focus on science has helped pull Baxter out of a slump.
(continued >>)
To continue reading this full article, you must be a subscriber to The Scientist.
You are only a few minutes away from unlimited access.
If you already have an online subscription, please Log-In Now.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
New to The Scientist? Register to get access to a selection of our content, interactive features and useful tools free without a subscription.
Subscribe to The Scientist to get unlimited access to our premium content
Get unlimited access to this article and over 20 years of The Scientist archives. You won’t miss a word – all for as little as $4.95. Subscribe now.The Scientist offers site licenses to institutions and organizations. Recommend us to your librarian and get online access through your place or work or study.